Kidney health Medicines Approved in the EU (EMA)

Medicines the European Medicines Agency has recommended for use in the European Union on this topic.

Each number has its full source under its own list below.

Medicines authorised in the EU

86 medicines (authorised now). Newest first. Each links to its EMA page.

At the source
  • Bopediat

    Active substance: furosemide

    EMEA/H/C/006617
  • Xoanacyl

    Active substance: ferric citrate coordination complex

    EMEA/H/C/006402
  • Welireg

    Active substance: belzutifan

    EMEA/H/C/005636
  • Axitinib Accord

    Active substance: axitinib

    EMEA/H/C/006206
  • Avzivi

    Active substance: bevacizumab

    EMEA/H/C/005574
  • Elucirem

    Active substance: Gadopiclenol

    EMEA/H/C/005626
  • Vueway

    Active substance: Gadopiclenol

    EMEA/H/C/006172
  • Vafseo

    Active substance: vadadustat

    EMEA/H/C/005131
  • Dapagliflozin Viatris

    Active substance: dapagliflozin

    EMEA/H/C/006006
  • Sorafenib Accord

    Active substance: sorafenib tosilate

    EMEA/H/C/005921
  • Vegzelma

    Active substance: bevacizumab

    EMEA/H/C/005534
  • Kapruvia

    Active substance: difelikefalin

    EMEA/H/C/005612
  • Kerendia

    Active substance: finerenone

    EMEA/H/C/005200
  • Evrenzo

    Active substance: roxadustat

    EMEA/H/C/004871
  • Jayempi

    Active substance: azathioprine

    EMEA/H/C/005055

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

Benchmarks on kidney health

Countries side by side on public measures for this topic.

All benchmarks

EU medicine approvals on related topics

All topics

Acuitas market sizes and forecasts are only in our full reports. How we use public data.